King Pharmaceuticals KG AmTrust Reinsurance — % of Total Net premiums earned

Similar metrics at other companies

ALLAllstate Protection — Premium earned as percentage of consolidated revenues

85.2%+1.2pp

UHALInvestments — Premiums Percentage Assumed To Net

24.5%+15.3pp

ESN

ESNTPercentage of Amount Assumed to Net

0%—

KMPRPercentage of Amount Assumed to Net

0%—

CIAPercentage of Amount Assumed to Net

0%—

GLAmerican Income — % of Total

38%-1.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept kg:PremiumsEarnedNetAsPercentOfTotal.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's amtrust reinsurance — % of total net premiums earned.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's amtrust reinsurance — % of total net premiums earned?: King Pharmaceuticals (KG) reported amtrust reinsurance — % of total net premiums earned of 9.7% in Q4 2025.
What does amtrust reinsurance — % of total net premiums earned mean?: Represents the segment's contribution to the total earned premium revenue of the organization. It provides insight into the segment's role in driving the company's recurring top-line financial performance.